marijuana stocks

Two Rivers Water & Farming Company (TURV)

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013
Total Revenue 1,072   10   5   1,037  
Cost of Revenue 786 1,075
Gross Profit 286   10   5   (38)
Operating Expenses
Research Development
Selling General and Administrative 703 1,005 838 (1,777)
Non Recurring
Others 129 124 125 172
Total Operating Expenses
Operating Income or Loss (546) (1,119) (958) 1,567  
Income from Continuing Operations
Total Other Income/Expenses Net (99) (71) 11 (160)
Earnings Before Interest And Taxes (644) (1,191) (947) 1,407
Interest Expense 217 307 335 268
Income Before Tax (861) (1,498) (1,282) 1,139
Income Tax Expense
Minority Interest 4 (5) (10)
Net Income From Continuing Ops (857) (1,503) (1,282) 1,049
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (857) (1,033) (1,752) 1,922  
Preferred Stock And Other Adjustments (483) (177) (470)
Net Income Applicable To Common Shares (1,340) (1,210) (2,222) 1,129  

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Jushi Holdings Inc. (JUSHF) to Host Fourth Quarter and Full Year 2020 and First Quarter 2021 Financial Results Conference Call

Jushi Holdings Inc. to Host Fourth Quarter and Full Year 2020 and…

IONIC Brands Corp. (IONC.CN) Signs LOI to Acquire Licensed Cannabis Volatile Extraction and Manufacturing Assets of Kavry Managment LLC

IONIC Brands Signs LOI to Acquire Licensed Cannabis Volatile Extraction and Manufacturing…

American Premium Water Corporation (HIPH) Completes Acquisition of CBD Topical Brand plant + body essentials

American Premium Water Corp. (OTC: HIPH) Completes Acquisition of CBD Topical Brand…

INSYS Therapeutics, Inc. (INSY) Initiates Court-Supervised Process to Facilitate Asset Sales and Address Legacy Liabilities

INSYS Therapeutics Initiates Court-Supervised Process to Facilitate Asset Sales and Address Legacy…